Skip to content

Prospective Observational Study on the Effects of Long-Acting Human Growth Hormone Analogues on Quality of Life and Quality of Sleep

Prospective Observational Study on the Effects of Long-Acting Human Growth Hormone Analogues on Quality of Life and Quality of Sleep - Prospective Observational Study on the Effects of Long-Acting Human Growth Hormone Analogues on Quality of Life and Quality of Sleep

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000048580
Enrollment
20
Registered
2024-12-31
Start date
2022-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult growth hormone deficiency

Interventions

None listed

Sponsors

Faculty of Internal Medicine, University of Miyazaki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Patients with AGHD requiring Somapacitan therapy (2) Patients who are 20 years of age or older at the time of obtaining consent (3) Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on their full understanding of the study.

Exclusion criteria

Exclusion criteria: (1) Patients with contraindications to Somapacitan (2) Other subjects deemed inappropriate as research subjects by the investigator

Design outcomes

Primary

MeasureTime frame
Change in Athens Insomnia Scale score before and after starting or changing Somapacitan

Secondary

MeasureTime frame
1) Change in SF-36 score before and after starting or changing Somapacitan 2) Change in blood examination before and after starting or changing Somapacitan 3) Change in body composition before and after starting or changing Somapacitan 4) Adverse events during the observation period

Countries

Japan

Contacts

Public ContactTaisuke Uchida

Department of Internal Medicine, Faculty of Internal Medicine, University of Miyazaki Division of Hematology, Diabetes, and Endocrinology

taisuke_uchida@med.miyazaki-u.ac.jp0985859121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026